E3 ubiquitin ligase RNF168 mediates 53BP1 stability and sensitivity of cancer cells to DNA damaging agents and irradiation [37, 38], and RNF168 expression is inhibited by rapamycin (mTOR)-ribosomal S6 kinase (S6K) signaling [38]. Here, TP53BP1 is linked to cancer.